References: Laryngeal and hypopharyngeal cancer detailed guide
American Cancer Society. Cancer Facts & Figures 2014. Atlanta, Ga: American Cancer Society; 2014.
American Joint Committee on Cancer. Larynx. In: AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010: 57-62.
American Joint Committee on Cancer. Pharynx. In: AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010: 41-49.
Atkinson JC, Harvey KE, Domingo DL, et al. Oral and dental phenotype of dyskeratosis congenita. Oral Dis. 2008;14:419-427.
Benninger MS, Gillen J, Thieme P, Jacobson B, Dragovich J. Factors associated with recurrence and voice quality following radiation therapy for T1 and T2 glottic carcinomas. Laryngoscope. 1994 Mar;104(3 Pt 1):294-8.
Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006;354:567-578.
Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP. Trends in incidence and prognosis for head and neck cancer in the United States: A site-specific analysis of the SEER database. Int J Cancer. 2005;114:806-816.
Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349:2091-2098.
Forastiere AA, Zhang Q, Weber RS, et al. Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol. 2013;31(7):845-852. Epub 2012 Nov 26.
Furusaka T, Matsuda A, Tanaka A, Matsuda H, Ikeda M. Superselective intra-arterial chemoradiation therapy for functional laryngeal preservation in advanced squamous cell carcinoma of the glottic larynx. Acta Otolaryngol. 2013;133(6):633-640. Epub 2013 Feb 11.
Gold KA, Lee HY, Kim ES. Targeted therapies in squamous cell carcinoma of the head and neck. Cancer. 2009;115:922-935.
Haddad RI, Shin DM. Recent advances in head and neck cancer. N Engl J Med. 2008;359:1143-1154.
Howlader N, Noone AM, Krapcho M, et al (eds). SEER Cancer Statistics Review, 1975-2010, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2010/, based on November 2012 SEER data submission, posted to the SEER website, April 2013.
Kikidis D, Vlastarakos PV, Manolopoulos L, Yiotakis I. Continuation of smoking after treatment of laryngeal cancer: an independent prognostic factor? ORL J Otorhinolaryngol Relat Spec. 2012;74(5):250-4. Epub 2012 Oct 13.
Kutler DI, Auerbach AD, Satagopan J, et al. High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. Arch Otolaryngol Head Neck Surg. 2003;129:106-112.
Mendenhall WM, Werning JW, Pfister DG. Treatment of head and neck cancers. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 9th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2011: 729-780.
Moyer JS, Wolf GT. Advanced stage cancer of the larynx. Part A: General principles and management. In: Harrison LB, Sessions RB, Hong WK, eds. Head and Neck Cancer: A Multidisciplinary Approach. Philadelphia, Pa: Lippincott Williams and Wilkins; 2009: 367-384.
National Cancer Institute. Physician Data Query (PDQ). Hypopharyngeal Cancer Treatment. 12/12/2013. Accessed at www.cancer.gov/cancertopics/pdq/treatment/hypopharyngeal/HealthProfessional on February 19, 2014.
National Cancer Institute. Physician Data Query (PDQ). Laryngeal Cancer Treatment. 2/15/2013. Accessed at www.cancer.gov/cancertopics/pdq/treatment/laryngeal/HealthProfessional on February 19, 2014.
National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers. V.1.2012. Accessed at www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf on October 22, 2012.
Romesser PB, Riaz N, Ho AL, Wong RJ, Lee NY. Cancer of the head and neck. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 5th ed. Philadelphia, Pa: Elsevier; 2014:1037-1070.
Vermorken JB, Mesia R, Rivera F, et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med. 2008;359:1116-1127.
Last Medical Review: 04/08/2014
Last Revised: 04/17/2014